This trial is active, not recruiting.

Condition psychological stress
Treatment psychological education program for nurses
Sponsor Massachusetts General Hospital
Start date March 2012
End date January 2013
Trial size 42 participants
Trial identifier NCT01593683, MGH 2011-P-002799


The purpose of this study is to test a brief education program for oncology nurses, to enhance their skills for managing psychosocial stressors associated with providing direct patient care. The investigators will explore efficacy of the intervention for reducing psychological stress and medical errors.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Allocation randomized
Endpoint classification efficacy study
Intervention model parallel assignment
Masking open label
Primary purpose supportive care
Patients receive the psychological education program upon study enrollment.
psychological education program for nurses
Approximately 4 weekly one-hour group sessions led by study clinicians and 1 optional individual session with a single study clinician.
(No Intervention)
Participants are assigned to a 16-week wait-list period upon enrollment. Participants are invited to receive the psychological education program following the waitlist period.

Primary Outcomes

Change from baseline in psychological stress as measured by the Perceived Stress Scale and the Maslach Burnout Inventory
time frame: At approximately 16 and 32 weeks post-baseline

Secondary Outcomes

Change in from baseline in medical errors as measured by the Medical Errors Questionnaire
time frame: At approximately 16 and 32 weeks post-baseline

Eligibility Criteria

Male or female participants at least 18 years old.

Inclusion Criteria: - Must have RN degree - Must be employed as an oncology nurse in an inpatient, infusion, or ambulatory care unit Exclusion Criteria: - Participation in earlier pilot trial of the intervention

Additional Information

Official title Waitlist-controlled Trial of a Psychological Education Program for Nurses
Principal investigator William F Pirl, MD, MPH
Trial information was received from ClinicalTrials.gov and was last updated in July 2013.
Information provided to ClinicalTrials.gov by Massachusetts General Hospital.